Lung Cancer
-
Camrelizumab – NSCLC | HongKong DengYue Medicine
-
Vizimpro (Dacomitinib) – NSCLC | HongKong DengYue Medicine
-
Alecensa (Alectinib) – NSCLC | HongKong DengYue Medicine
-
Keytruda (Pembrolizumab) – NSCLC | HongKong DengYue Medicine
-
Opdivo (Nivolumab) – NSCLC | HongKong DengYue Medicine
-
Zykadia (Ceritinib) – NSCLC | HongKong DengYue Medicine
-
Fukewai (Anlotinib Hydrochloride) – NSCLC | HongKong DengYue Medicine
-
Lazertinib | Non-Small Cell Lung Cancer | HongKong DengYue Medicine
-
Zenocutuzumab-Zbco｜Non-Small Cell Lung Cancer｜HongKong DengYue Medicine
-
Ensartinib | Non-small Cell Lung Cancer | HongKong DengYue Medicine
-
Encorafenib｜Non-Small Cell Lung Cancer｜HongKong DengYue Medicine
-
Tarlatamab-Dlle｜Extensive-Stage Small Cell Lung Cancer
-
Rezivertinib Mesylate Capsules｜Non-Small Cell Lung Cancer (NSCLC)
-
Capmatinib｜Non-Small Cell Lung Cancer (NSCLC)
-
Selpercatinib｜Thyroid Cancer｜HongKong DengYue Medicine
-
Lorbrena (Lorlatinib) – Lymphoma Kinase | HongKong DengYue Medicine
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights